Roche Holding AG (RHHBY)
OTCMKTS · Delayed Price · Currency is USD
49.85
-0.55 (-1.09%)
At close: Apr 2, 2026
Roche Holding AG Revenue
In the year 2025, Roche Holding AG had annual revenue of 63.36B CHF with 1.54% growth. Roche Holding AG had revenue of 31.51B in the half year ending December 31, 2025, with 5.64% growth.
Revenue
63.36B CHF
Revenue Growth
+1.54%
P/S Ratio
3.99
Revenue / Employee
613.62K CHF
Employees
103,249
Market Cap
318.88B USD
Revenue Chart
* This company reports financials in CHF.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 63.36B | 961.00M | 1.54% |
| Dec 31, 2024 | 62.40B | 1.95B | 3.23% |
| Dec 31, 2023 | 60.44B | -5.37B | -8.16% |
| Dec 31, 2022 | 65.81B | -36.00M | -0.05% |
| Dec 31, 2021 | 65.85B | 5.51B | 9.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Sofgen Pharma | 373.80M |
| Glass House Brands | 181.98M |
| Elite Pharmaceuticals | 140.12M |
| Tian'an Technology Group | 2.12M |
| Northwest Biotherapeutics | 937.00K |
| Comjoyful International Company | 564.97K |
Roche Holding AG News
- 12 hours ago - Trump Administration Unveils Up to 100% Tariff on Branded Drugs - WSJ
- 12 hours ago - Trump threatens 100% tariff on US drug makers that don't strike deals to lower prices - The Guardian
- 14 hours ago - Drugmakers face 100% tariff unless they cut prices or produce drugs in US - Reuters
- 14 hours ago - Global pharma companies that have publicly announced Trump drug pricing agreements - Reuters
- 4 days ago - Roche launches the cobas MPX-E assay, a new 4-in-1 donor screening test to further safeguard the global blood supply - GlobeNewsWire
- 6 days ago - Vector Institute Extends Collaboration With Roche - GlobeNewsWire
- 10 days ago - Roche launches the cobas eplex respiratory pathogen panel 3, a fast and comprehensive test to help clinicians treat patients with respiratory infections, in CE markets - PRNewsWire
- 10 days ago - Roche inaugurates new research home for the Institute of Human Biology, pioneering human model systems to accelerate drug discovery and development - GlobeNewsWire